VA12011 |
1056634-68-4 |
CYT 387 |
C23H22N6O2 |
VA12012 |
941678-49-5 |
Ruxolitinib |
|
VA12014 |
918504-65-1 |
PLX4032 |
|
VA12015 |
1028486-01-2 |
4-[[9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-2-methoxybenzoic acid |
C27H20ClFN4O4 |
VA12013 |
19171-19-8 |
Pomalidomide |
C13H11N3O4 |
VA12016 |
1110813-31-4 |
pf-299804 |
|
VA12017 |
905854-02-6 |
2,5-Pyrrolidinedione,3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-, (3R,4R)- |
C23H19N3O2 |
VA12019 |
1202757-89-8 |
AVL-292 (CC-292) |
|
VA12020 |
936563-96-1 |
PCI-32765 |
|
VA12018 |
1202759-32-7 |
CNX-774 |
|
VA12021 |
175414-77-4 |
Voreloxin |
C18H19N5O4S |
VA12023 |
849217-68-1 |
XL184 |
|
VA12024 |
923604-59-5 |
(2R,3aR,10Z,11aS,12aR,14aR)-N-(Cyclopropylsulfonyl)-2,3,3a,4,5,6,7,8,9,11a,12,13,14,14a-tetradecahydro-2-[[7-methoxy-8-methyl-2-[4-(1-methylethyl)-2-thiazolyl]-4-quinolinyl]oxy]-5-methyl-4,14-dioxocyclopenta[c]cyclopropa[g][1,6]diazacyclotetradecine-12a(1 |
749.94 |
VA12022 |
763113-22-0 |
Olaparib |
C24H23FN4O3 |
VA12025 |
441798-33-0 |
Macitentan |
C19H20Br2N6O4S |
VA12026 |
278779-30-9 |
GW 4064 |
C28H22NO4Cl3 |
VA12028 |
475086-01-2 |
NS-304 |
C26H32N4O4S |
VA12029 |
625115-55-1 |
Riociguat |
C20H19FN8O2 |
VA12030 |
869113-09-7 |
1-Azoniabicyclo[2.2.2]octane, 4-(hydroxydiphenylmethyl)-1-[2-(phenylmethoxy)ethyl]-, bromide (1:1) |
C29H34NO2+.Br- |
VA12027 |
1218918-62-7 |
MK-7246 |
|
VA12031 |
868049-49-4 |
6-Hydroxy-8-[(1R)-1-hydroxy-2-[[2-(4-methoxyphenyl)-1,1-dimethylethyl]amino]ethyl]-2H-1,4-benzoxazin-3(4H)-one |
C21H26N2O5 |
VA12033 |
608141-41-9 |
ApreMilast |
C22H24N2O7S |
VA12034 |
402567-16-2 |
[1,1'-Biphenyl]-4-propanoic acid, α-[(2,6-difluorobenzoyl)amino]-4'-(ethoxymethyl)-2',6'-dimethoxy-, (αS)- |
C27H27F2NO6 |
VA12032 |
503070-58-4 |
Vilanterol |
|
VA12035 |
1370261-96-3 |
P505-15 (PRT062607) |
|
VA12036 |
901119-35-5 |
Fostamatinib |
C23H26N6O9FP |
VA12037 |
1151516-14-1 |
Lesinurad sodium |
|
VA12039 |
1345614-59-6 |
AM-095 |
|
VA12040 |
856866-72-3 |
3-[3-Fluoro-4-[6-(2-methyl-2H-tetrazol-5-yl)-3-pyridinyl]phenyl]-5-(hydroxymethyl)-2-oxazolidinone |
C17H15N6O3F |
VA12038 |
609799-22-6 |
Tasimelteon |
C15H19NO2 |
VA12041 |
956136-95-1 |
LCQ-908 |
|
VA12043 |
848344-36-5 |
2-Benzothiazoleacetonitrile,a-[2-[[4-(4-morpholinylmethyl)phenyl]methoxy]-4-pyrimidinyl]- |
C25H23N5O2S |
VA12044 |
832720-36-2 |
Elagolix sodium; NBI 56418NA |
C32H29N3O5F5-.Na+ |
VP50373 |
22536-63-6 |
2-Chloro-4-methoxypyrimidine |
C5H5N2OCl |
VA12042 |
899805-25-5 |
Tanzisertib (CC-930) |
|
VP50374 |
189956-45-4 |
4-[(4-Hydroxy-2-pyrimidinyl)amino]benzonitrile |
C11H8N4O |
VP50376 |
41840-27-1 |
4,6-Dimethyl-2-mercaptopyrimidine sodium salt |
C6H7N2S-.Na+ |
VP50377 |
14001-63-9 |
4-METHYL-2-(METHYLSULFANYL)PYRIMIDINE |
C6H8N2S |
VP50378 |
17321-93-6 |
2-Amino-4-methyl-5-bromopyrimidine |
C5H6N3Br |
VP50375 |
|
2-hydroxy-4,6-dimethylpyrimidine |
|